Artificial Cornea and Corneal Implant Market worth $599 million by 2026 - Exclusive Report by MarketsandMarkets Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026 , published by MarketsandMarkets, the global Artificial Cornea Market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026.
Browse in-depth TOC on Artificial Cornea and Corneal Implant Market
102 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182165973
The Corneal Implant Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government i
The Corneal Implant Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.
The artificial cornea segment is projected to witness fastest growth during the forecast period
On the basis of type, the artificial cornea and corneal implants market is segmented into human cornea and artificial cornea. The artificial cornea segment is projected to witness fastest growth during the forecast period. An artificial corneal transplant, also known as keratoprosthesis (KPro), enables the restoration of vision in conditions wherein the cornea and the eye surface is affected or damaged. The scarcity of human eye donors has resulted in the development of innovative solutions such as artificial corneas. Additionally, individuals
Alabama Nonprofit Partners with Huntsville Genetics Company to Cure Blinding Diseases
News provided by
Share this article
Share this article
BIRMINGHAM, Ala., Jan. 27, 2021 /PRNewswire/ Two Alabama-based organizations are partnering to find cures for common diseases that cause blindness for millions of people worldwide.
Advancing Sight Network partnered with Kailos Genetics to find genetic causes of blinding eye diseases.
In an effort to help medical researchers develop new treatments and cures for blinding eye diseases, Advancing Sight Network and Kailos Genetics created the OcularGeneScreen®, a new genetic screening panel, to be used with eye tissue from post-mortem eye donors. The screening will help determine which genes are associated with eye diseases like age-related macular degeneration (AMD), glaucoma, and Fuch s Dystrophy.